ACTRN12614000732684CompletedPhase 4
The effect of omega-3 supplementation on adverse cardiovascular (CV) events among Indigenous Australians with stable coronary artery disease: A randomized controlled trial
South Australian Health and Medical Research Institute0 sites220 target enrollmentStarted: July 10, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Enrollment
- 220
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •* Men or women, self-identified as Indigenous
- •* Aged over 18 years
- •* Have confirmed Coronary Artery Disease [CAD] (according to nationally consistent definitions):
- •* Prior hospitalisation for myocardial infarction/acute coronary syndrome
- •* Prior revascularisation
- •* Proven coronary stenosis >50%
Exclusion Criteria
- •* Non-residents of South Australia or Alice Springs, NT.
- •* Patients with significant neurological/cognitive impairment that prevents consent
- •* Hypersensitivity or documented allergy to the study drug
- •* Known bleeding disorder or end-stage renal disease requiring dialysis
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effects of Omega-3 Supplementation, associated or not with Physical Exercise in patients with Metabolic Syndromeinsulin resistancediabetes mellitus type 2inflammationC18.452.394.968.500.570ObesityRBR-8cb536gniversidade Federal de Juiz de Fora
Completed
Phase 2
Effects omega-3 fatty acid supplementation in the treatment of diabetesIRCT201502255623N36Kashan University of Medical Sciences60
Completed
Phase 2
Effect of omega-3 fatty acids supplementation in polycystic ovary syndrome patientsIRCT201011083664N3Vice-chancellor for research, Tabriz University of Medical Sciences64
Completed
Phase 2
Effect of omega-3 fatty acids supplementation on serum levels of malondialdehyde, total antioxidant capacity and paraoxonase1 in polycystic ovary syndrome patientspolycystic ovary syndrome.Polycystic ovarian syndromeIRCT201106243664N5utritional Research Center,Tabriz University of Medical Sciences60
Recruiting
Phase 3
Omega-3 on vascular function in hemodialysis patientsEnd stage renal disease (ESRD).End stage renal diseaseN18.6IRCT20220611055142N1Tabriz University of Medical Sciences36